日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

P342 Trans-continental analysis of over, 2000 Inflammatory Bowel Disease patients implicates geography, disease type, and exposure to immunosuppression as drivers of SARS-CoV-2 seroprevalence: data from the ICARUS-IBD Consortium

P342 对超过 2000 名炎症性肠病患者的跨大陆分析表明,地理位置、疾病类型和免疫抑制暴露是 SARS-CoV-2 血清阳性率的驱动因素:来自 ICARUS-IBD 联盟的数据

Waljee, Akbar K; Sauder, Kay; Patel, Anand; Segar, Sandeep; Zhang, Yiwei; Zhu, Ji; Stidham, Ryan W; Balis, Ulysses; Higgins, Peter D R; Rabinowitz, K M; Navon, M; Edelman-Klapper, H; Zittan, E; Bar-Gil Shitrit, A; Goren, I; Avni-Biron, I; Ollech, J E; Lichtenstein, L; Banai-Eran, H; Yanai, H; Snir, Y; Pauker, M H; Friedenberg, A; Levy-Barda, A; Segal, A; Broitman, Y; Maoz, E; Ovadia, B; Aharoni Golan, M; Shachar, E; Ben-Horin, S; Perets, T T; Ben Zvi, H; Eliakim, R; Barkan, R; Goren, S; Krugliak, N; Werbner, M; Alter, J; Dessau, M; Gal-Tanamy, M; Cohen, D; Freund, N T; Dotan, I; Attauabi, M; Dahlerup, J F; Poulsen, A; Hansen, M R; Vester-Andersen, M K; Eraslan, S; Prahm, A P; Pedersen, N; Larsen, L; Jess, T; Neumann, A; Haderslev, K V; Molazahi, A; Lødrup, A B; Glerup, H; Oppfeldt, A M; Jensen, M D; Theede, K; Kiszka-Kanowitz, M; Seidelin, J B; Burisch, J; Jørgensen, K K; Syversen, S W; Jyssum, I; Tveter, A T; Tran, T T; Sexton, J; Provan, S A; Mjaaland, S; Warren, D J; Kvien, T K; Grødeland, G; Nissen-Meyer, L S; Ricanek, P; Chopra, A; Andersson, A M; Kro, G B; Jahnsen, J; Munthe, L A; Haavardsholm, E A; Vaage, J T; Lund-Johansen, F; Goll, G L; Attauabi, M; Dahlerup, J F; Poulsen, A; Hansen, M R; Vester-Andersen, M K; Eraslan, S; Prahm, A P; Pedersen, N; Larsen, L; Jess, T; Neumann, A; Haderslev, K V; Molazahi, A; Lødrup, A B; Glerup, H; Oppfeldt, A M; Jensen, M D; Theede, K; Kiszka-Kanowitz, M; Seidelin, J B; Burisch, J; Wong, S Y; Helmus, D; Marlow, L; Martinez Pazos, V; Brann, S; Wellens, J; Kedia, S; Mak, J W Y; Bergemalm, D; Argollo, M; Zaltman, C; Steinwurz, F; Rubin, D; Allez, M; Halfvarson, J; Abreu, M T; Lindsay, J; Dutta, U; Silverberg, M S; Ng, S C; Ahuja, V; Watanabe, K; Vermeire, S; Colombel, J F; Satsangi, J

DOP20 Functional viral neutralisation responses after SARS-CoV-2 infection in Inflammatory Bowel Disease patients receiving infusion therapies: Report from the ICARUS-IBD Consortium

DOP20 功能性病毒中和反应在接受输注治疗的炎症性肠病患者中 SARS-CoV-2 感染后的变化:来自 ICARUS-IBD 联盟的报告

Lima, Svetlana F; Longman, Randy S; Zacharopoulou, E; Orfanoudaki, E; Kitsou, V; Tzouvala, M; Tribonias, G; Mantzaris, G J; Viazis, N; Christidou, A; Almpani, F; Karmiris, K; Theodoropoulou, A; Tsafaridou, M; Michopoulos, S; Zampeli, E; Papathanasiou, E; Michalopoulos, G; Tigkas, S; Karatzas, P; Laoudi, E; Liatsos, C; Kyriakos, N; Mylonas, I; Theocharis, G; Koutroubakis, I E; Bamias, G; Volkers, A; Wieske, L; van Dam, K; Steenhuis, M; Stalman, E; Kummer, L; van Kempen, Z; Killestein, J; Tas, S; Boekel, L; Wolbink, G; Takkenberg, B; Spuls, P; Bosma, A; Rutgers, B; Verschuuren, J; van Ouwerkerk, L; van der Woude, D; van Paassen, P; Busch, M; Brusse, E; Hijnen, D; ten Brinke, A; Verstegen, N; D’Haens, G; van Ham, M; Kuijpers, T; Rispens, T; Löwenberg, M; Eftimov, F; Attauabi, M; Dahlerup, J F; Poulsen, A; Hansen, M R; Vester-Andersen, M K; Eraslan, S; Prahm, A P; Pedersen, N; Larsen, L; Jess, T; Neumann, A; Haderslev, K V; Molazahi, A; Lødrup, A B; Glerup, H; Oppfeldt, A M; Jensen, M D; Theede, K; Kiszka-Kanowitz, M; Seidelin, J B; Burisch, J; Bezzio, C; Guarino, A D; Fiorino, G; Armuzzi, A; Ribaldone, D G; Furfaro, F; Pugliese, D; Vernero, M; Variola, A; Gerardi, V; Scucchi, L; Viganò, C; Caprioli, F A; Roselli, J; Coppini, F; Ardizzone, S; Onali, S; Zingone, F; Daperno, M; Cortellezzi, C; Carparelli, S; Soriano, A; Manes, G; Saibeni, S; Attauabi, M; Dahlerup, J F; Poulsen, A; Rosager Hansen, M; Vester-Andersen, M K; Eraslan, S; Prahm, A P; Pedersen, N; Larsen, L; Jess, T; Neumann, A; Haderslev, K V; Molazahi, A; Lødrup, A B; Glerup, H; Oppfeldt, A M; Jensen, M D; Theede, K; Kiszka-Kanowitz, M; Seidelin, J B; Burisch, J; Vuitton, L; Bourrier, A; Uzzan, M; Nachury, M; Amiot, A; Roblin, X; Allez, M; Altwegg, R; Vidon, M; Bourreille, A; Serrero, M; Pelletier, A L; Filippi, J; Gilletta, C; Simon, M; Laharie, D; Nahon, S; Duveau, N; Biron, A; Viennot, S; Abitbol, V; Elgharabawy, Y; Peyrin-Biroulet, L; Wellens, J; Edmans, M; Obolski, U; Marlow, L; Brann, S; Dunachie, S; Eyre, D; Helmus, D; Barnes, E; Colombel, J F; Wong, S Y; Klenerman, P; Lindsay, J O; Thompson, C P; Satsangi, J

DOP20 Functional viral neutralisation responses after SARS-CoV-2 infection in Inflammatory Bowel Disease patients receiving infusion therapies: Report from the ICARUS-IBD Consortium

DOP20 功能性病毒中和反应在接受输注治疗的炎症性肠病患者中 SARS-CoV-2 感染后的变化:来自 ICARUS-IBD 联盟的报告

Afonina, Inna S; Frasca, Loredana; Palmer, Gaby; Delavy, Margot; Burdet, Charles; Sertour, Natacha; Chatelier, Emmanuelle Le; Doquier, Jean-Denis; Volant, Stevenn; Ghozlane, Amine; Grall, Nathalie; Duval, Xavier; Mentré, France; Duffy, Darragh; D'Enfert, Christophe; Bougnoux, Marie-Elisabeth; Wellens, J; Edmans, M; Obolski, U; Marlow, L; Brann, S; Dunachie, S; Eyre, D; Helmus, D; Barnes, E; Colombel, J F; Wong, S Y; Klenerman, P; Lindsay, J O; Thompson, C P; Satsangi, J

P342 Trans-continental analysis of over, 2000 Inflammatory Bowel Disease patients implicates geography, disease type, and exposure to immunosuppression as drivers of SARS-CoV-2 seroprevalence: data from the ICARUS-IBD Consortium

P342 对超过 2000 名炎症性肠病患者的跨大陆分析表明,地理位置、疾病类型和免疫抑制暴露是 SARS-CoV-2 血清阳性率的驱动因素:来自 ICARUS-IBD 联盟的数据

Scott, Ian C; Mount, Julie; Barry, Jane; Kirkham, Bruce; Kearsley-Fleet, Lianne; Jain, Sarthak; Baildam, Eileen; Beresford, Michael W; Douglas, Sharon; Foster, Helen E; Southwood, Taunton R; Hyrich, Kimme L; Wong, S Y; Helmus, D; Marlow, L; Martinez Pazos, V; Brann, S; Wellens, J; Kedia, S; Mak, J W Y; Bergemalm, D; Argollo, M; Zaltman, C; Steinwurz, F; Rubin, D; Allez, M; Halfvarson, J; Abreu, M T; Lindsay, J; Dutta, U; Silverberg, M S; Ng, S C; Ahuja, V; Watanabe, K; Vermeire, S; Colombel, J F; Satsangi, J

Serum proteomic profiling at diagnosis predicts clinical course, and need for intensification of treatment in inflammatory bowel disease

诊断时血清蛋白质组学分析可预测炎症性肠病的临床病程和强化治疗的必要性

Kalla, R; Adams, A T; Bergemalm, D; Vatn, S; Kennedy, N A; Ricanek, P; Lindstrom, J; Ocklind, A; Hjelm, F; Ventham, N T; Ho, G T; Petren, C; Repsilber, D; Söderholm, J; Pierik, M; D'Amato, M; Gomollón, F; Olbjorn, C; Jahnsen, J; Vatn, M H; Halfvarson, J; Satsangi, J

A protein-truncating R179X variant in RNF186 confers protection against ulcerative colitis.

RNF186 中的蛋白质截短变体 R179X 可预防溃疡性结肠炎

Rivas Manuel A, Graham Daniel, Sulem Patrick, Stevens Christine, Desch A Nicole, Goyette Philippe, Gudbjartsson Daniel, Jonsdottir Ingileif, Thorsteinsdottir Unnur, Degenhardt Frauke, Mucha Sören, Kurki Mitja I, Li Dalin, D'Amato Mauro, Annese Vito, Vermeire Severine, Weersma Rinse K, Halfvarson Jonas, Paavola-Sakki Paulina, Lappalainen Maarit, Lek Monkol, Cummings Beryl, Tukiainen Taru, Haritunians Talin, Halme Leena, Koskinen Lotta L E, Ananthakrishnan Ashwin N, Luo Yang, Heap Graham A, Visschedijk Marijn C, MacArthur Daniel G, Neale Benjamin M, Ahmad Tariq, Anderson Carl A, Brant Steven R, Duerr Richard H, Silverberg Mark S, Cho Judy H, Palotie Aarno, Saavalainen Päivi, Kontula Kimmo, Färkkilä Martti, McGovern Dermot P B, Franke Andre, Stefansson Kari, Rioux John D, Xavier Ramnik J, Daly Mark J, Barrett J, de Lane K, Edwards C, Hart A, Hawkey C, Jostins L, Kennedy N, Lamb C, Lee J, Lees C, Mansfield J, Mathew C, Mowatt C, Newman B, Nimmo E, Parkes M, Pollard M, Prescott N, Randall J, Rice D, Satsangi J, Simmons A, Tremelling M, Uhlig H, Wilson D, Abraham C, Achkar J P, Bitton A, Boucher G, Croitoru K, Fleshner P, Glas J, Kugathasan S, Limbergen J V, Milgrom R, Proctor D, Regueiro M, Schumm P L, Sharma Y, Stempak J M, Targan S R, Wang M H

MicroRNAs: new players in IBD

微小RNA:炎症性肠病的新角色

Kalla, R; Ventham, N T; Kennedy, N A; Quintana, J F; Nimmo, E R; Buck, A H; Satsangi, J

The impact of smoking in Crohn's disease: no smoke without fire

吸烟对克罗恩病的影响:无风不起浪

Aldhous, Marian C; Satsangi, J

The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications

蒙特利尔炎症性肠病分类:争议、共识及意义

Satsangi, J; Silverberg, M S; Vermeire, S; Colombel, J-F

Anti-Saccharomyces cerevisiae antibodies (ASCA) in Crohn's disease are associated with disease severity but not NOD2/CARD15 mutations

克罗恩病中的抗酿酒酵母抗体(ASCA)与疾病严重程度相关,但与NOD2/CARD15突变无关。

Walker, L J; Aldhous, M C; Drummond, H E; Smith, B R K; Nimmo, E R; Arnott, I D R; Satsangi, J